Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05370391
Other study ID # 20210853
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 9, 2022
Est. completion date January 2025

Study information

Verified date December 2023
Source University of Miami
Contact Aileen Kangavary, B.A.
Phone 3059849852
Email camatprogram@miami.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this protocol is to examine treatment outcomes of youth receiving the Comprehensive Behavioral Intervention for Tics (CBIT) and better understand the predictors, moderators, mediators and/or mechanisms of change for this intervention.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date January 2025
Est. primary completion date January 2025
Accepts healthy volunteers No
Gender All
Age group 5 Years to 17 Years
Eligibility Inclusion criteria - A current diagnosis of a Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Tic disorder (e.g., Tourette's Disorder/syndrome, Persistent (Chronic) Motor or Vocal Tic Disorder, or Provisional Tic Disorder) or caregiver/youth report of clinically impairing tic symptoms - Ability for youth to speak/read English sufficiently - At least one parent/caregiver available to sign study consent forms, remain present during assessments, and fill out study questionnaires in English. Exclusion criteria - A current diagnosis of psychosis, bipolar disorder, intellectual disability, acute suicidality, alcohol/substance dependence, or eating disorder. - Youth currently receiving psychotherapy elsewhere and/or have previously received CBIT. - Currently suicidal or who have engaged in suicidal behaviors within the past 6 months will be excluded - Youth currently taking psychotropic medication for a co-morbid psychiatric illness will be included without a wash-out period (to not delay treatment).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Comprehensive Behavioral Intervention for Tics (CBIT)
The CBIT (or CBIT-JR) intervention consists of a minimum of 6 sessions of 50-minutes each week in an individual or group setting.

Locations

Country Name City State
United States University of Miami Coral Gables Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical Global Impression (CGI) - Severity Scale Scores A single-item clinician-reported measure used to assess the severity of the youth's illness at the time of assessment. The CGI-S is rated on a 7-point scale ranging from 1 (slight psychiatric illness) to 7 (extremely severe psychiatric illness). Higher scores indicate greater symptom severity. Change from baseline CGI-S scores to 12 weeks.
Primary Clinical Global Impression (CGI) - Improvement Scores A single-item clinician-reported measure used to assess clinical changes in youth symptomology over the course of treatment. The CGI-I is rated on a 7-point scale ranging from 1 (very much improved since the initiation of treatment) to 7 (very much worse since the initiation of treatment). Higher scores indicate greater symptom improvement since baseline Change from baseline CGI-I scores to 12 weeks from the start of treatment.
Primary Parent Tic Questionnaire (PTQ) A 28-item parent-reported measure used to assess the frequency and intensity of different motor and vocal tic symptoms in youth. The PTQ evaluates tic frequency on a 4-point scale, ranging from 1 (constant) to 4 (weekly), and intensity on a 3-point scale, ranging from 1 (mild) to 3 (very noticeable). This is done for each presenting tic. Composite total scores on the PTQ range from 2-138. Higher summed composite score indicating more tics. Change from pre-screen PTQ scores, to baseline, to 6 weeks, and 12 weeks from the start of treatment.
Primary Premonitory Urge Tic Scale (PUTS) A 10-item self-reported measure that assess the severity of premonitory urges. The PUTS is rated on a 4-point scale ranging from 1 (not at all true) to 4 (very much true). Total scores range from 10-40 with higher scores indicating greater symptom severity. Change from baseline PUTS scores, to 6 weeks, to 12 weeks from the start of treatment.
Primary Youth Quality of Life (YQOL) Instrument - Short Form (SF) Scores A 15-item self-reported measure of quality of life for youth ages 11-18. The YQOL-SF is rated on a 10-point scale from 0 (not at all) to 10 (very much). Scores range from 0 to 100, with higher scores indicating a higher quality of life. Change from baseline YQOL Scores, to 6 weeks, to 12 weeks from the start of treatment.
Primary Yale Global Tic Severity Scale (YGTSS) - Total Tic Scores The YGTSS is a clinician-rated interview assessing both motor and phonic tic symptoms across 5 domains: total number, frequency, intensity, complexity, and interference. Items from each domain for motor and phonic tics are summed to produce the YGTSS Total Tic Score, which ranges from 0-50. Higher scores on the YGTSS - Total Tic Score suggests greater tic severity. Change from pre-screen YGTSS Total Tic Scores, to 6 weeks, and 12 weeks from the start of treatment.
Primary Yale Global Tic Severity Scale (YGTSS) - Total Motor Tic Scores The YGTSS is a clinician-rated interview assessing both motor and phonic tic symptoms across 5 domains: total number, frequency, intensity, complexity, and interference. Items from each domain for motor tics are summed to produce the YGTSS Total Motor Tic Score, which ranges from 0-25. Higher scores on the YGTSS - Total Motor Score suggests greater motor tic severity. Change from pre-screen YGTSS Total Motor Tic Scores, to 6 weeks, and 12 weeks from the start of treatment.
Primary Yale Global Tic Severity Scale (YGTSS) - Total Phonic Tic Score The YGTSS is a clinician-rated interview assessing both motor and phonic tic symptoms across 5 domains: total number, frequency, intensity, complexity, and interference. Items from each domain for phonic tics are summed to produce the YGTSS Total Phonic Tic Score, which ranges from 0-25. Higher scores on the YGTSS - Total Phonic Score suggests greater phonic tic severity. Change from pre-screen YGTSS Total Phonic Tic Scores, to 6 weeks, and 12 weeks from the start of treatment.
Primary Yale Global Tic Severity Scale (YGTSS) - Overall Tic Related Impairment Scores The YGTSS is a clinician-rated interview assessing both motor and phonic tic symptoms across 5 domains: total number, frequency, intensity, complexity, and interference. The YGTSS includes a separate impairment scale that reflects overall tic-related impairment, ranging from 0-50. Higher scores on this scale suggests greater tic impairment. Change from YGTSS Overall Tic Related Impairment Scores pre-screen, to 6 weeks, and 12 weeks from the start of treatment.
Primary Yale Global Tic Severity Scale (YGTSS) - Global Severity Score The YGTSS is a clinician-rated interview assessing both motor and phonic tic symptoms across 5 domains: total number, frequency, intensity, complexity, and interference. The YGTSS includes a separate global severity scale that ranges from 0-100. Higher scores on this scale suggests greater global tic severity. Change from pre-screen YGTSS Global Severity Score, to 6 weeks, and 12 weeks from the start of treatment.
Secondary Revised Children's Anxiety and Depression Scale - Child and Revised Parent Short (RCADS-25/RCADS-P-25) Scores A 25-item self- and parent-reported scales measuring symptoms of anxiety and depression in youth. Items are rated on a 4-point scale from 1 (Never) to 4 (always) with scores ranging from 0 to 75. A score of 70 or higher indicates high severity, above clinical threshold. Change from baseline RCADS-P scores, to 6 weeks, to 12 weeks from the start of treatment.
Secondary Tic Accommodation and Reactions Scale (TARS) Scores A 35-item parent-reported measure used to assess reactions and consequences that occur in response to youth' tics. Items focus on events at home, in school, and in other public places. The TARS is rated on a 4-point scale from 0 (not at all in the past week) to 3 (many times in the past week). Scores range from 0 to 105, with higher scores indicating greater frequency of reaction and consequences in response to their child's tics. Change from baseline TARS scores, to 6 weeks, to 12 weeks from the start of treatment.
See also
  Status Clinical Trial Phase
Completed NCT04007913 - Incorporating teleCBIT Into a Hospital-Based Tic Program N/A
Completed NCT00241176 - Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 4
Completed NCT04498364 - Extinction Learning in Adults With Tourette Syndrome N/A
Recruiting NCT03844919 - TICS: Transcranial Magnetic Stimulation for Intervening in Children With Tourette's Syndrome (CIHR) N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT00231985 - Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder Phase 2
Recruiting NCT06050369 - Objective Characterizatoion of Repetitive Behaviors N/A
Completed NCT04578912 - Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics N/A
Completed NCT03483493 - Online Remote Behavioural Intervention for Tics (ORBIT) N/A
Recruiting NCT06408662 - Remote Delivery of a Mindfulness-based Intervention for Tics N/A
Withdrawn NCT04765085 - Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for Tics N/A
Completed NCT02676492 - A Naturalistic Study Investigating Sleep and Cognitive Learning in Children With and Without Tic Disorders N/A
Recruiting NCT01860300 - Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus N/A
Completed NCT00001667 - Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases N/A
Completed NCT00056420 - Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement N/A
Completed NCT04128397 - An Exploratory Study of Continuous Theta Burst Stimulation (cTBS) Based on fMRI in the Treatment of Tic Disorder N/A
Recruiting NCT05547854 - Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program N/A
Recruiting NCT05047705 - Investigating Distress Tolerance in Adults With Tourette Syndrome N/A
Completed NCT03564132 - Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder Phase 2
Completed NCT03239210 - Effects of Ondansetron in Obsessive-compulsive and Tic Disorders Phase 4